Nano-scale delivery can complete difficult "distribution" tasks

Australian researchers have developed a miniature nanodride vector that can effectively kill "superbugs" hidden in cells by delivering antibiotics to infected cells that are difficult to reach during routine administration. This approach is expected to be used in the future to combat a variety of deadly infectious diseases.
bacteria that are resistant to a variety of antibiotics are known as "superbugs" and are unable to enter the bacteria when they are infected.
researchers at the University of South Australia and the University of Adelaide report in the international journal Antibiotics that they used mesoconiosilic nanoparticles to make the vector and loaded the anti-tuberculosis drug lyferpin into it, successfully "distributed" it into infected cells, killing TB bacteria in hidden cells.
first author of the paper, Santoni Subramaniam of the University of South Australia, explains that nano-drug vectors containing antibiotics are "eaten" by infected cells when they enter the body, killing bacteria more quickly.
, a professor at the University of South Australia and author of the paper, believes the technology could be used to fight superbugs. They hope to complete human clinical trials in the next few years and hope that this approach will also play a role in urinary tract infections, bone infections and wound infections. (Source: Xinhua News Agency)
relevant paper information: